SSI Weekly Highlights: Liquidations, Mergers, and Strategic Developments in Biopharma
288 Views10 Mar 2025 01:54
Abrdn Diversified Income And Growth is undergoing a wind-down, trading at a 30% discount to NAV, with potential liquidation acceleration.
What is covered in the Full Insight:
- Abrdn Diversified Income And Growth
- Acelyrin - Merger Arbitrage
- Sage Therapeutics - Lawsuit and CMO Resignation
- OCI N.V. - Methanol Sale Update
- Pacific Current Group - Tender Extension
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)